In summary, the progression of AAA is marked by a reduction in the number or density of contractile smooth muscle cells in the aortic wall, driven by apoptosis and phenotypic transformation under the influence of the enhanced CXCL12/CXCR4 axis. This evidence concerns the gene CXCL12 and triple-A syndrome.